,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #hije  ,,in ,,the ,,house ,,of  
,,representatives  ,december #h1        
#bjbj,mr4 ,van ,drew introduced the     
following bill2 which was referred to   
the ,committee on ,energy and ,commerce 
,a ,,bill  ,to amend the ,federal ,food1
 ,drug1 and ,cosmetic ,act to reduce the
 threat of counterfeit drugs to the     
pharmaceutical supply chain1 and to make
 the pharmaceutical supply chain more   
robust1 while ensuring the authenticity1
 content1 purity1 and manufacturing     
location and batch number of drugs      
7including ,,covid-#ai therapeutics and 
vaccines7 and allowing patient          
verification of authenticity1 and for   
other purposes4  #a4 ,short title ,this 
,act may be cited as the ,supply ,chain 
,security and ,pharmaceutical           
,authentication ,act of #bjbj4  #b4     
,packages subject to pharmaceutical     
distribution supply chain requirements  
,subparagraph 7,b7 of section #eha7aa7  
of the ,federal ,food1 ,drug1 and       

,cosmetic ,act 7#ba ,u4,s4,c4           
#cfj;eee7#aa77 is amended to read as    
follows3  7,b7 ,individual saleable unit
 ,for purposes of this paragraph1 an    
individual saleable unit is the smallest
 solid oral dosage form of product1 or  
other individual solid oral dosage form 
of product1 introduced into commerce by 
the manufacturer or repackager4  4